Aspirin may help reduce the risk of recurrent venous thromboembolism (VTE) following the cessation of anticoagulant therapy, reports a new study. VTE is a potentially life-threatening condition in which larger veins in the pelvis and leg become inflamed, and a clot forms as a consequence. These clots can break off and now called emboli travel up the venous system to the heart, and then out into the lung circulation, where they block pulmonary arteries. This can cause illness ranging from cough and shortness of breath, to sudden death.
Aspirin may help reduce the risk of recurrent venous thromboembolism (VTE) following the cessation of anticoagulant therapy, reports a new study. VTE is a potentially life-threatening condition in which larger veins in the pelvis and leg become inflamed, and a clot forms as a consequence. These clots can break off and now called emboli travel up the venous system to the heart, and then out into the lung circulation, where they block pulmonary arteries. This can cause illness ranging from cough and shortness of breath, to sudden death.